Global Personalized mRNA Cancer Vaccine Therapy Market Insights, Forecast to 2031

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Personalized mRNA Cancer Vaccine Therapy Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Personalized mRNA Cancer Vaccine Therapy Market Size Growth Rate by Type, 2020 VS 2024 VS 2031
  • 1.2.2 LNP Delivery System
  • 1.2.3 DC Cell Delivery System
  • 1.2.4 Others
• 1.3 Market by Application
  • 1.3.1 Global Personalized mRNA Cancer Vaccine Therapy Market Size Growth Rate by Application, 2020 VS 2024 VS 2031
  • 1.3.2 Solid Tumors
  • 1.3.3 Non-Solid Tumors
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global Personalized mRNA Cancer Vaccine Therapy Revenue Estimates and Forecasts 2020-2031
• 2.2 Global Revenue by Region
  • 2.2.1 Global Personalized mRNA Cancer Vaccine Therapy Revenue by Region: 2020 VS 2024 VS 2031
  • 2.2.2 Global Personalized mRNA Cancer Vaccine Therapy Revenue by Region (2020-2031)
  • 2.2.3 Global Personalized mRNA Cancer Vaccine Therapy Revenue Market Share by Region (2020-2031)
• 2.3 Global Personalized mRNA Cancer Vaccine Therapy Sales Estimates and Forecasts 2020-2031
• 2.4 Global Sales by Region
  • 2.4.1 Global Personalized mRNA Cancer Vaccine Therapy Sales by Region: 2020 VS 2024 VS 2031
  • 2.4.2 Global Personalized mRNA Cancer Vaccine Therapy Sales by Region (2020-2031)
  • 2.4.3 Global Personalized mRNA Cancer Vaccine Therapy Sales Market Share by Region (2020-2031)
• 2.5 US & Canada
• 2.6 Europe
• 2.7 China
• 2.8 Asia (excluding China)
• 2.9 Middle East, Africa and Latin America

3 Competition by Manufacturers

• 3.1 Global Sales by Manufacturers
  • 3.1.1 Global Personalized mRNA Cancer Vaccine Therapy Sales by Manufacturers (2020-2025)
  • 3.1.2 Global Personalized mRNA Cancer Vaccine Therapy Sales Market Share by Manufacturers (2020-2025)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Personalized mRNA Cancer Vaccine Therapy in 2024
• 3.2 Global Revenue by Manufacturers
  • 3.2.1 Global Personalized mRNA Cancer Vaccine Therapy Revenue by Manufacturers (2020-2025)
  • 3.2.2 Global Personalized mRNA Cancer Vaccine Therapy Revenue Market Share by Manufacturers (2020-2025)
  • 3.2.3 Global Top 10 and Top 5 Companies by Personalized mRNA Cancer Vaccine Therapy Revenue in 2024
• 3.3 Global Key Players of Personalized mRNA Cancer Vaccine Therapy, Industry Ranking, 2023 VS 2024
• 3.4 Global Personalized mRNA Cancer Vaccine Therapy Sales Price by Manufacturers (2020-2025)
• 3.5 Analysis of Competitive Landscape
  • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.5.2 Global Personalized mRNA Cancer Vaccine Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.6 Global Key Manufacturers of Personalized mRNA Cancer Vaccine Therapy, Manufacturing Base Distribution and Headquarters
• 3.7 Global Key Manufacturers of Personalized mRNA Cancer Vaccine Therapy, Product Offered and Application
• 3.8 Global Key Manufacturers of Personalized mRNA Cancer Vaccine Therapy, Date of Enter into This Industry
• 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Sales by Type
  • 4.1.1 Global Personalized mRNA Cancer Vaccine Therapy Historical Sales by Type (2020-2025)
  • 4.1.2 Global Personalized mRNA Cancer Vaccine Therapy Forecasted Sales by Type (2026-2031)
  • 4.1.3 Global Personalized mRNA Cancer Vaccine Therapy Sales Market Share by Type (2020-2031)
• 4.2 Global Revenue by Type
  • 4.2.1 Global Personalized mRNA Cancer Vaccine Therapy Historical Revenue by Type (2020-2025)
  • 4.2.2 Global Personalized mRNA Cancer Vaccine Therapy Forecasted Revenue by Type (2026-2031)
  • 4.2.3 Global Personalized mRNA Cancer Vaccine Therapy Revenue Market Share by Type (2020-2031)
• 4.3 Global Price by Type
  • 4.3.1 Global Personalized mRNA Cancer Vaccine Therapy Price by Type (2020-2025)
  • 4.3.2 Global Personalized mRNA Cancer Vaccine Therapy Price Forecast by Type (2026-2031)

5 Market Size by Application

• 5.1 Global Sales by Application
  • 5.1.1 Global Personalized mRNA Cancer Vaccine Therapy Historical Sales by Application (2020-2025)
  • 5.1.2 Global Personalized mRNA Cancer Vaccine Therapy Forecasted Sales by Application (2026-2031)
  • 5.1.3 Global Personalized mRNA Cancer Vaccine Therapy Sales Market Share by Application (2020-2031)
• 5.2 Global Revenue by Application
  • 5.2.1 Global Personalized mRNA Cancer Vaccine Therapy Historical Revenue by Application (2020-2025)
  • 5.2.2 Global Personalized mRNA Cancer Vaccine Therapy Forecasted Revenue by Application (2026-2031)
  • 5.2.3 Global Personalized mRNA Cancer Vaccine Therapy Revenue Market Share by Application (2020-2031)
• 5.3 Global Price by Application
  • 5.3.1 Global Personalized mRNA Cancer Vaccine Therapy Price by Application (2020-2025)
  • 5.3.2 Global Personalized mRNA Cancer Vaccine Therapy Price Forecast by Application (2026-2031)

6 US & Canada

• 6.1 US & Canada Market Size by Type
  • 6.1.1 US & Canada Personalized mRNA Cancer Vaccine Therapy Sales by Type (2020-2031)
  • 6.1.2 US & Canada Personalized mRNA Cancer Vaccine Therapy Revenue by Type (2020-2031)
• 6.2 US & Canada Market Size by Application
  • 6.2.1 US & Canada Personalized mRNA Cancer Vaccine Therapy Sales by Application (2020-2031)
  • 6.2.2 US & Canada Personalized mRNA Cancer Vaccine Therapy Revenue by Application (2020-2031)
• 6.3 US & Canada Market Size by Country
  • 6.3.1 US & Canada Personalized mRNA Cancer Vaccine Therapy Revenue by Country: 2020 VS 2024 VS 2031
  • 6.3.2 US & Canada Personalized mRNA Cancer Vaccine Therapy Revenue by Country (2020-2031)
  • 6.3.3 US & Canada Personalized mRNA Cancer Vaccine Therapy Sales by Country (2020-2031)
  • 6.3.4 US
  • 6.3.5 Canada

7 Europe

• 7.1 Europe Market Size by Type
  • 7.1.1 Europe Personalized mRNA Cancer Vaccine Therapy Sales by Type (2020-2031)
  • 7.1.2 Europe Personalized mRNA Cancer Vaccine Therapy Revenue by Type (2020-2031)
• 7.2 Europe Market Size by Application
  • 7.2.1 Europe Personalized mRNA Cancer Vaccine Therapy Sales by Application (2020-2031)
  • 7.2.2 Europe Personalized mRNA Cancer Vaccine Therapy Revenue by Application (2020-2031)
• 7.3 Europe Market Size by Country
  • 7.3.1 Europe Personalized mRNA Cancer Vaccine Therapy Revenue by Country: 2020 VS 2024 VS 2031
  • 7.3.2 Europe Personalized mRNA Cancer Vaccine Therapy Sales by Country (2020-2031)
  • 7.3.3 Europe Personalized mRNA Cancer Vaccine Therapy Revenue by Country (2020-2031)
  • 7.3.4 Germany
  • 7.3.5 France
  • 7.3.6 U.K.
  • 7.3.7 Italy
  • 7.3.8 Russia

8 China

• 8.1 China Market Size by Type
  • 8.1.1 China Personalized mRNA Cancer Vaccine Therapy Sales by Type (2020-2031)
  • 8.1.2 China Personalized mRNA Cancer Vaccine Therapy Revenue by Type (2020-2031)
• 8.2 China Market Size by Application
  • 8.2.1 China Personalized mRNA Cancer Vaccine Therapy Sales by Application (2020-2031)
  • 8.2.2 China Personalized mRNA Cancer Vaccine Therapy Revenue by Application (2020-2031)

9 Asia (excluding China)

• 9.1 Asia Market Size by Type
  • 9.1.1 Asia Personalized mRNA Cancer Vaccine Therapy Sales by Type (2020-2031)
  • 9.1.2 Asia Personalized mRNA Cancer Vaccine Therapy Revenue by Type (2020-2031)
• 9.2 Asia Market Size by Application
  • 9.2.1 Asia Personalized mRNA Cancer Vaccine Therapy Sales by Application (2020-2031)
  • 9.2.2 Asia Personalized mRNA Cancer Vaccine Therapy Revenue by Application (2020-2031)
• 9.3 Asia Market Size by Region
  • 9.3.1 Asia Personalized mRNA Cancer Vaccine Therapy Revenue by Region: 2020 VS 2024 VS 2031
  • 9.3.2 Asia Personalized mRNA Cancer Vaccine Therapy Revenue by Region (2020-2031)
  • 9.3.3 Asia Personalized mRNA Cancer Vaccine Therapy Sales by Region (2020-2031)
  • 9.3.4 Japan
  • 9.3.5 South Korea
  • 9.3.6 China Taiwan
  • 9.3.7 Southeast Asia
  • 9.3.8 India
  • 9.3.9 Australia

10 Middle East, Africa and Latin America

• 10.1 Middle East, Africa and Latin America Market Size by Type
  • 10.1.1 Middle East, Africa and Latin America Personalized mRNA Cancer Vaccine Therapy Sales by Type (2020-2031)
  • 10.1.2 Middle East, Africa and Latin America Personalized mRNA Cancer Vaccine Therapy Revenue by Type (2020-2031)
• 10.2 Middle East, Africa and Latin America Market Size by Application
  • 10.2.1 Middle East, Africa and Latin America Personalized mRNA Cancer Vaccine Therapy Sales by Application (2020-2031)
  • 10.2.2 Middle East, Africa and Latin America Personalized mRNA Cancer Vaccine Therapy Revenue by Application (2020-2031)
• 10.3 Middle East, Africa and Latin America Market Size by Country
  • 10.3.1 Middle East, Africa and Latin America Personalized mRNA Cancer Vaccine Therapy Revenue by Country: 2020 VS 2024 VS 2031
  • 10.3.2 Middle East, Africa and Latin America Personalized mRNA Cancer Vaccine Therapy Revenue by Country (2020-2031)
  • 10.3.3 Middle East, Africa and Latin America Personalized mRNA Cancer Vaccine Therapy Sales by Country (2020-2031)
  • 10.3.4 Brazil
  • 10.3.5 Mexico
  • 10.3.6 Turkey
  • 10.3.7 Israel
  • 10.3.8 GCC Countries

11 Corporate Profile

• 11.1 Moderna
  • 11.1.1 Moderna Company Information
  • 11.1.2 Moderna Overview
  • 11.1.3 Moderna Personalized mRNA Cancer Vaccine Therapy Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.1.4 Moderna Personalized mRNA Cancer Vaccine Therapy Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Moderna Recent Developments
• 11.2 BioNTech
  • 11.2.1 BioNTech Company Information
  • 11.2.2 BioNTech Overview
  • 11.2.3 BioNTech Personalized mRNA Cancer Vaccine Therapy Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.2.4 BioNTech Personalized mRNA Cancer Vaccine Therapy Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 BioNTech Recent Developments
• 11.3 Neocura
  • 11.3.1 Neocura Company Information
  • 11.3.2 Neocura Overview
  • 11.3.3 Neocura Personalized mRNA Cancer Vaccine Therapy Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.3.4 Neocura Personalized mRNA Cancer Vaccine Therapy Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 Neocura Recent Developments
• 11.4 Everest Medicines
  • 11.4.1 Everest Medicines Company Information
  • 11.4.2 Everest Medicines Overview
  • 11.4.3 Everest Medicines Personalized mRNA Cancer Vaccine Therapy Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.4.4 Everest Medicines Personalized mRNA Cancer Vaccine Therapy Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 Everest Medicines Recent Developments
• 11.5 Curevac
  • 11.5.1 Curevac Company Information
  • 11.5.2 Curevac Overview
  • 11.5.3 Curevac Personalized mRNA Cancer Vaccine Therapy Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.5.4 Curevac Personalized mRNA Cancer Vaccine Therapy Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 Curevac Recent Developments
• 11.6 Genentech
  • 11.6.1 Genentech Company Information
  • 11.6.2 Genentech Overview
  • 11.6.3 Genentech Personalized mRNA Cancer Vaccine Therapy Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.6.4 Genentech Personalized mRNA Cancer Vaccine Therapy Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 Genentech Recent Developments
• 11.7 Merck
  • 11.7.1 Merck Company Information
  • 11.7.2 Merck Overview
  • 11.7.3 Merck Personalized mRNA Cancer Vaccine Therapy Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.7.4 Merck Personalized mRNA Cancer Vaccine Therapy Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 Merck Recent Developments
• 11.8 Transgene
  • 11.8.1 Transgene Company Information
  • 11.8.2 Transgene Overview
  • 11.8.3 Transgene Personalized mRNA Cancer Vaccine Therapy Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.8.4 Transgene Personalized mRNA Cancer Vaccine Therapy Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 Transgene Recent Developments
• 11.9 Likang Life Sciences
  • 11.9.1 Likang Life Sciences Company Information
  • 11.9.2 Likang Life Sciences Overview
  • 11.9.3 Likang Life Sciences Personalized mRNA Cancer Vaccine Therapy Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.9.4 Likang Life Sciences Personalized mRNA Cancer Vaccine Therapy Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9.5 Likang Life Sciences Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Personalized mRNA Cancer Vaccine Therapy Industry Chain Analysis
• 12.2 Personalized mRNA Cancer Vaccine Therapy Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Personalized mRNA Cancer Vaccine Therapy Production Mode & Process
• 12.4 Personalized mRNA Cancer Vaccine Therapy Sales and Marketing
  • 12.4.1 Personalized mRNA Cancer Vaccine Therapy Sales Channels
  • 12.4.2 Personalized mRNA Cancer Vaccine Therapy Distributors
• 12.5 Personalized mRNA Cancer Vaccine Therapy Customers

13 Personalized mRNA Cancer Vaccine Therapy Market Dynamics

• 13.1 Personalized mRNA Cancer Vaccine Therapy Industry Trends
• 13.2 Personalized mRNA Cancer Vaccine Therapy Market Drivers
• 13.3 Personalized mRNA Cancer Vaccine Therapy Market Challenges
• 13.4 Personalized mRNA Cancer Vaccine Therapy Market Restraints

14 Key Findings in the Global Personalized mRNA Cancer Vaccine Therapy Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 15.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Author Details
• 15.3 Disclaimer

List of Tables

Table 1. Global Personalized mRNA Cancer Vaccine Therapy Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Major Manufacturers of LNP Delivery System

Table 3. Major Manufacturers of DC Cell Delivery System

Table 4. Major Manufacturers of Others

Table 5. Global Personalized mRNA Cancer Vaccine Therapy Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 6. Global Personalized mRNA Cancer Vaccine Therapy Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 7. Global Revenue by Region (2020-2025) & (US$ Million)

Table 8. Global Revenue Market Share by Region (2020-2031)

Table 9. Global Personalized mRNA Cancer Vaccine Therapy Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)

Table 10. Global Personalized mRNA Cancer Vaccine Therapy Sales by Region (2020-2031) & (Units)

Table 11. Global Sales Market Share by Region (2020-2031)

Table 12. Global Personalized mRNA Cancer Vaccine Therapy Sales by Manufacturers (2020-2025) & (Units)

Table 13. Global Personalized mRNA Cancer Vaccine Therapy Sales Share by Manufacturers (2020-2025)

Table 14. Global Personalized mRNA Cancer Vaccine Therapy Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 15. Global Personalized mRNA Cancer Vaccine Therapy Revenue Market Share by Manufacturers (2020-2025)

Table 16. Global Key Players of Personalized mRNA Cancer Vaccine Therapy, Industry Ranking, 2023 VS 2024 VS 2024

Table 17. Personalized mRNA Cancer Vaccine Therapy Price by Manufacturers (2020-2025) & (US$/Unit)

Table 18. Global Personalized mRNA Cancer Vaccine Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 19. Global Personalized mRNA Cancer Vaccine Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized mRNA Cancer Vaccine Therapy as of 2024)

Table 20. Global Key Manufacturers of Personalized mRNA Cancer Vaccine Therapy, Manufacturing Base Distribution and Headquarters

Table 21. Global Key Manufacturers of Personalized mRNA Cancer Vaccine Therapy, Product Offered and Application

Table 22. Global Key Manufacturers of Personalized mRNA Cancer Vaccine Therapy, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Personalized mRNA Cancer Vaccine Therapy Sales by Type (2020-2025) & (Units)

Table 25. Global Personalized mRNA Cancer Vaccine Therapy Sales by Type (2026-2031) & (Units)

Table 26. Global Sales Share by Type (2020-2031)

Table 27. Global Personalized mRNA Cancer Vaccine Therapy Revenue by Type (2020-2025) & (US$ Million)

Table 28. Global Personalized mRNA Cancer Vaccine Therapy Revenue by Type (2026-2031) & (US$ Million)

Table 29. Global Revenue Share by Type (2020-2031)

Table 30. Personalized mRNA Cancer Vaccine Therapy Price by Type (2020-2025) & (US$/Unit)

Table 31. Global Personalized mRNA Cancer Vaccine Therapy Price Forecast by Type (2026-2031) & (US$/Unit)

Table 32. Global Personalized mRNA Cancer Vaccine Therapy Sales by Application (2020-2025) & (Units)

Table 33. Global Personalized mRNA Cancer Vaccine Therapy Sales by Application (2026-2031) & (Units)

Table 34. Global Sales Share by Application (2020-2031)

Table 35. Global Personalized mRNA Cancer Vaccine Therapy Revenue by Application (2020-2025) & (US$ Million)

Table 36. Global Personalized mRNA Cancer Vaccine Therapy Revenue by Application (2026-2031) & (US$ Million)

Table 37. Global Revenue Share by Application (2020-2031)

Table 38. Personalized mRNA Cancer Vaccine Therapy Price by Application (2020-2025) & (US$/Unit)

Table 39. Global Personalized mRNA Cancer Vaccine Therapy Price Forecast by Application (2026-2031) & (US$/Unit)

Table 40. US & Canada Sales by Type (2020-2031) & (Units)

Table 41. US & Canada Revenue by Type (2020-2031) & (US$ Million)

Table 42. US & Canada Sales by Application (2020-2031) & (Units)

Table 43. US & Canada Revenue by Application (2020-2031) & (US$ Million)

Table 44. US & Canada Personalized mRNA Cancer Vaccine Therapy Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 45. US & Canada Revenue by Country (2020-2031) & (US$ Million)

Table 46. US & Canada Sales by Country (2020-2031) & (Units)

Table 47. Europe Sales by Type (2020-2031) & (Units)

Table 48. Europe Revenue by Type (2020-2031) & (US$ Million)

Table 49. Europe Sales by Application (2020-2031) & (Units)

Table 50. Europe Revenue by Application (2020-2031) & (US$ Million)

Table 51. Europe Personalized mRNA Cancer Vaccine Therapy Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 52. Europe Sales by Country (2020-2031) & (Units)

Table 53. Europe Revenue by Country (2020-2031) & (US$ Million)

Table 54. China Sales by Type (2020-2031) & (Units)

Table 55. China Revenue by Type (2020-2031) & (US$ Million)

Table 56. China Sales by Application (2020-2031) & (Units)

Table 57. China Revenue by Application (2020-2031) & (US$ Million)

Table 58. Asia Sales by Type (2020-2031) & (Units)

Table 59. Asia Revenue by Type (2020-2031) & (US$ Million)

Table 60. Asia Sales by Application (2020-2031) & (Units)

Table 61. Asia Revenue by Application (2020-2031) & (US$ Million)

Table 62. Asia Personalized mRNA Cancer Vaccine Therapy Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 63. Asia Revenue by Region (2020-2031) & (US$ Million)

Table 64. Asia Sales by Region (2020-2031) & (Units)

Table 65. Middle East, Africa and Latin America Sales by Type (2020-2031) & (Units)

Table 66. Middle East, Africa and Latin America Revenue by Type (2020-2031) & (US$ Million)

Table 67. Middle East, Africa and Latin America Sales by Application (2020-2031) & (Units)

Table 68. Middle East, Africa and Latin America Revenue by Application (2020-2031) & (US$ Million)

Table 69. Middle East, Africa and Latin America Personalized mRNA Cancer Vaccine Therapy Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 70. Middle East, Africa and Latin America Revenue by Country (2020-2031) & (US$ Million)

Table 71. Middle East, Africa and Latin America Sales by Country (2020-2031) & (Units)

Table 72. Moderna Company Information

Table 73. Moderna Description and Major Businesses

Table 74. Moderna Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 75. Moderna Product Model Numbers, Pictures, Descriptions and Specifications

Table 76. Moderna Recent Developments

Table 77. BioNTech Company Information

Table 78. BioNTech Description and Major Businesses

Table 79. BioNTech Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 80. BioNTech Product Model Numbers, Pictures, Descriptions and Specifications

Table 81. BioNTech Recent Developments

Table 82. Neocura Company Information

Table 83. Neocura Description and Major Businesses

Table 84. Neocura Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 85. Neocura Product Model Numbers, Pictures, Descriptions and Specifications

Table 86. Neocura Recent Developments

Table 87. Everest Medicines Company Information

Table 88. Everest Medicines Description and Major Businesses

Table 89. Everest Medicines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 90. Everest Medicines Product Model Numbers, Pictures, Descriptions and Specifications

Table 91. Everest Medicines Recent Developments

Table 92. Curevac Company Information

Table 93. Curevac Description and Major Businesses

Table 94. Curevac Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 95. Curevac Product Model Numbers, Pictures, Descriptions and Specifications

Table 96. Curevac Recent Developments

Table 97. Genentech Company Information

Table 98. Genentech Description and Major Businesses

Table 99. Genentech Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 100. Genentech Product Model Numbers, Pictures, Descriptions and Specifications

Table 101. Genentech Recent Developments

Table 102. Merck Company Information

Table 103. Merck Description and Major Businesses

Table 104. Merck Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 105. Merck Product Model Numbers, Pictures, Descriptions and Specifications

Table 106. Merck Recent Developments

Table 107. Transgene Company Information

Table 108. Transgene Description and Major Businesses

Table 109. Transgene Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 110. Transgene Product Model Numbers, Pictures, Descriptions and Specifications

Table 111. Transgene Recent Developments

Table 112. Likang Life Sciences Company Information

Table 113. Likang Life Sciences Description and Major Businesses

Table 114. Likang Life Sciences Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 115. Likang Life Sciences Product Model Numbers, Pictures, Descriptions and Specifications

Table 116. Likang Life Sciences Recent Developments

Table 117. Key Raw Materials Lists

Table 118. Raw Materials Key Suppliers Lists

Table 119. Distributors List

Table 120. Customers List

Table 121. Market Trends

Table 122. Market Drivers

Table 123. Market Challenges

Table 124. Market Restraints

Table 125. Research Programs/Design for This Report

Table 126. Key Data Information from Secondary Sources

Table 127. Key Data Information from Primary Sources

List of Figures

Figure 1. Personalized mRNA Cancer Vaccine Therapy Product Picture

Figure 2. Global Personalized mRNA Cancer Vaccine Therapy Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Personalized mRNA Cancer Vaccine Therapy Market Share by Type: 2024 & 2031

Figure 4. LNP Delivery System Product Picture

Figure 5. DC Cell Delivery System Product Picture

Figure 6. Others Product Picture

Figure 7. Global Personalized mRNA Cancer Vaccine Therapy Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 8. Global Personalized mRNA Cancer Vaccine Therapy Market Share by Application: 2024 & 2031

Figure 9. Solid Tumors

Figure 10. Non-Solid Tumors

Figure 11. Personalized mRNA Cancer Vaccine Therapy Report Years Considered

Figure 12. Global Personalized mRNA Cancer Vaccine Therapy Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Personalized mRNA Cancer Vaccine Therapy Revenue (2020-2031) & (US$ Million)

Figure 14. Global Personalized mRNA Cancer Vaccine Therapy Revenue by Region (2020-2031) (US$ Million)

Figure 15. Global Personalized mRNA Cancer Vaccine Therapy Revenue Market Share by Region in Percentage: 2024 Versus 2031

Figure 16. Global Personalized mRNA Cancer Vaccine Therapy Revenue Market Share by Region (2020-2031)

Figure 17. Global Personalized mRNA Cancer Vaccine Therapy Sales (2020-2031) & (Units)

Figure 18. Global Personalized mRNA Cancer Vaccine Therapy Sales (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)

Figure 19. Global Personalized mRNA Cancer Vaccine Therapy Sales Market Share by Region (2020-2031)

Figure 20. US & Canada Personalized mRNA Cancer Vaccine Therapy Sales YoY (2020-2031) & (Units)

Figure 21. US & Canada Personalized mRNA Cancer Vaccine Therapy Revenue YoY (2020-2031) & (US$ Million)

Figure 22. Europe Personalized mRNA Cancer Vaccine Therapy Sales YoY (2020-2031) & (Units)

Figure 23. Europe Personalized mRNA Cancer Vaccine Therapy Revenue YoY (2020-2031) & (US$ Million)

Figure 24. China Personalized mRNA Cancer Vaccine Therapy Sales YoY (2020-2031) & (Units)

Figure 25. China Personalized mRNA Cancer Vaccine Therapy Revenue YoY (2020-2031) & (US$ Million)

Figure 26. Asia (excluding China) Personalized mRNA Cancer Vaccine Therapy Sales YoY (2020-2031) & (Units)

Figure 27. Asia (excluding China) Personalized mRNA Cancer Vaccine Therapy Revenue YoY (2020-2031) & (US$ Million)

Figure 28. Middle East, Africa and Latin America Personalized mRNA Cancer Vaccine Therapy Sales YoY (2020-2031) & (Units)

Figure 29. Middle East, Africa and Latin America Personalized mRNA Cancer Vaccine Therapy Revenue YoY (2020-2031) & (US$ Million)

Figure 30. Global Personalized mRNA Cancer Vaccine Therapy Sales Share by Manufacturers (2024)

Figure 31. The Personalized mRNA Cancer Vaccine Therapy Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2024

Figure 32. Global Personalized mRNA Cancer Vaccine Therapy Revenue Share by Manufacturers (2024)

Figure 33. The Top 5 and 10 Largest Manufacturers of Personalized mRNA Cancer Vaccine Therapy in the World: Market Share by Personalized mRNA Cancer Vaccine Therapy Revenue in 2024

Figure 34. Global Personalized mRNA Cancer Vaccine Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 35. Global Personalized mRNA Cancer Vaccine Therapy Sales Market Share by Type (2020-2031)

Figure 36. Global Personalized mRNA Cancer Vaccine Therapy Revenue Market Share by Type (2020-2031)

Figure 37. Global Personalized mRNA Cancer Vaccine Therapy Sales Market Share by Application (2020-2031)

Figure 38. Global Personalized mRNA Cancer Vaccine Therapy Revenue Market Share by Application (2020-2031)

Figure 39. US & Canada Personalized mRNA Cancer Vaccine Therapy Sales Market Share by Type (2020-2031)

Figure 40. US & Canada Personalized mRNA Cancer Vaccine Therapy Revenue Market Share by Type (2020-2031)

Figure 41. US & Canada Personalized mRNA Cancer Vaccine Therapy Sales Market Share by Application (2020-2031)

Figure 42. US & Canada Personalized mRNA Cancer Vaccine Therapy Revenue Market Share by Application (2020-2031)

Figure 43. US & Canada Personalized mRNA Cancer Vaccine Therapy Revenue Share by Country (2020-2031)

Figure 44. US & Canada Personalized mRNA Cancer Vaccine Therapy Sales Share by Country (2020-2031)

Figure 45. US Personalized mRNA Cancer Vaccine Therapy Revenue (2020-2031) & (US$ Million)

Figure 46. Canada Personalized mRNA Cancer Vaccine Therapy Revenue (2020-2031) & (US$ Million)

Figure 47. Europe Personalized mRNA Cancer Vaccine Therapy Sales Market Share by Type (2020-2031)

Figure 48. Europe Personalized mRNA Cancer Vaccine Therapy Revenue Market Share by Type (2020-2031)

Figure 49. Europe Personalized mRNA Cancer Vaccine Therapy Sales Market Share by Application (2020-2031)

Figure 50. Europe Personalized mRNA Cancer Vaccine Therapy Revenue Market Share by Application (2020-2031)

Figure 51. Europe Personalized mRNA Cancer Vaccine Therapy Sales Share by Country (2020-2031)

Figure 52. Europe Personalized mRNA Cancer Vaccine Therapy Revenue Share by Country (2020-2031)

Figure 53. Germany Personalized mRNA Cancer Vaccine Therapy Revenue (2020-2031) & (US$ Million)

Figure 54. France Personalized mRNA Cancer Vaccine Therapy Revenue (2020-2031) & (US$ Million)

Figure 55. U.K. Personalized mRNA Cancer Vaccine Therapy Revenue (2020-2031) & (US$ Million)

Figure 56. Italy Personalized mRNA Cancer Vaccine Therapy Revenue (2020-2031) & (US$ Million)

Figure 57. Russia Personalized mRNA Cancer Vaccine Therapy Revenue (2020-2031) & (US$ Million)

Figure 58. China Personalized mRNA Cancer Vaccine Therapy Sales Market Share by Type (2020-2031)

Figure 59. China Personalized mRNA Cancer Vaccine Therapy Revenue Market Share by Type (2020-2031)

Figure 60. China Personalized mRNA Cancer Vaccine Therapy Sales Market Share by Application (2020-2031)

Figure 61. China Personalized mRNA Cancer Vaccine Therapy Revenue Market Share by Application (2020-2031)

Figure 62. Asia Personalized mRNA Cancer Vaccine Therapy Sales Market Share by Type (2020-2031)

Figure 63. Asia Personalized mRNA Cancer Vaccine Therapy Revenue Market Share by Type (2020-2031)

Figure 64. Asia Personalized mRNA Cancer Vaccine Therapy Sales Market Share by Application (2020-2031)

Figure 65. Asia Personalized mRNA Cancer Vaccine Therapy Revenue Market Share by Application (2020-2031)

Figure 66. Asia Personalized mRNA Cancer Vaccine Therapy Revenue Share by Region (2020-2031)

Figure 67. Asia Personalized mRNA Cancer Vaccine Therapy Sales Share by Region (2020-2031)

Figure 68. Japan Personalized mRNA Cancer Vaccine Therapy Revenue (2020-2031) & (US$ Million)

Figure 69. South Korea Personalized mRNA Cancer Vaccine Therapy Revenue (2020-2031) & (US$ Million)

Figure 70. China Taiwan Personalized mRNA Cancer Vaccine Therapy Revenue (2020-2031) & (US$ Million)

Figure 71. Southeast Asia Personalized mRNA Cancer Vaccine Therapy Revenue (2020-2031) & (US$ Million)

Figure 72. India Personalized mRNA Cancer Vaccine Therapy Revenue (2020-2031) & (US$ Million)

Figure 73. Australia Personalized mRNA Cancer Vaccine Therapy Revenue (2020-2031) & (US$ Million)

Figure 74. Middle East, Africa and Latin America Personalized mRNA Cancer Vaccine Therapy Sales Market Share by Type (2020-2031)

Figure 75. Middle East, Africa and Latin America Personalized mRNA Cancer Vaccine Therapy Revenue Market Share by Type (2020-2031)

Figure 76. Middle East, Africa and Latin America Personalized mRNA Cancer Vaccine Therapy Sales Market Share by Application (2020-2031)

Figure 77. Middle East, Africa and Latin America Personalized mRNA Cancer Vaccine Therapy Revenue Market Share by Application (2020-2031)

Figure 78. Middle East, Africa and Latin America Personalized mRNA Cancer Vaccine Therapy Revenue Share by Country (2020-2031)

Figure 79. Middle East, Africa and Latin America Personalized mRNA Cancer Vaccine Therapy Sales Share by Country (2020-2031)

Figure 80. Brazil Personalized mRNA Cancer Vaccine Therapy Revenue (2020-2031) & (US$ Million)

Figure 81. Mexico Personalized mRNA Cancer Vaccine Therapy Revenue (2020-2031) & (US$ Million)

Figure 82. Turkey Personalized mRNA Cancer Vaccine Therapy Revenue (2020-2031) & (US$ Million)

Figure 83. Israel Personalized mRNA Cancer Vaccine Therapy Revenue (2020-2031) & (US$ Million)

Figure 84. GCC Countries Personalized mRNA Cancer Vaccine Therapy Revenue (2020-2031) & (US$ Million)

Figure 85. Value Chain

Figure 86. Personalized mRNA Cancer Vaccine Therapy Production Process

Figure 87. Channels of Distribution (Direct Vs Distribution)

Figure 88. Bottom-up and Top-down Approaches for This Report

Figure 89. Data Triangulation

Figure 90. Key Executives Interviewed